Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)

Cancer Chemotherapy and Pharmacology

Volumn 60, Issue 2, 2007, Pages 219-228

  Alemón Medina, Radamés ^a   Breña Valle, Matilde ^a   Muñoz Sánchez, José Luis ^b   Gracia Mora, María Isabel ^c   Ruiz Azuara, Lena ^c  

^a INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Casiope nas ; Copper based drugs; Genotoxicity; Lipid peroxidation; Oxidative damage; ROS

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CASIOPEINAS; CELL NUCLEUS DNA; COPPER DERIVATIVE; DNA FRAGMENT; ETHIDIUM BROMIDE; FLUORESCEIN DIACETATE; MALONALDEHYDE; MEMBRANE LIPID; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GENETIC DAMAGE; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; IC 50; LIPID PEROXIDATION; LYMPHOCYTE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; LYMPHOCYTES; NITRATES; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 34248377894     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0364-9     Document Type: Article

References (35)

1. Bortner CD, Oldenburg NBE, Cidlowski JA (1995) The role of DNA fragmentation in apoptosis. Trends Cell Biol 5:21-26
2. Cano SP (1999) Genotoxicidad de antineoplásicos de tipo organometálico. MSc Thesis, Escuela Nacional de Ciencias Biológicas, IPN
3. ®CASIOPEÍNA. Título de Marca. SECOFI, México
4. Chiou SH (1984) DNA-scission activities of ascorbate in the presence of metal chelates. J Biochem 96(4):1307-1310
5. Copeland WC, Wachsman JT, Johnson FM, Penta JS (2002) Mitochondrial DNA alterations in cancer. Cancer Invest 20(4):557-569
6. De Vizcaya-Ruiz A, Rivero-Müller A, Ruiz-Ramírez L, Howarth JA, Dobrota M (2003) Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II. Toxicology 194:103-113
7. De Vizcaya-Ruiz A, Rivero-Müller A, Ruiz-Ramirez L, Kass GE, Kelland LR, Orr RM, Dobrota M (2000) Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. Toxicol In Vitro 14(1):1-5
8. Dizdaroglu M, Auroma IO, Halliwell B (1990) Modification of bases in DNA by copper ion-1,10-phenanthroline complexes. Biochemistry 29:8447-8451
9. Faggiani R, Lock CJL, Lippert B (1980) Cleavage of DNA by coordination complexes. Superoxide formation in the oxidation of 1,10-phenanthroline-cuprous complexes by oxygen-relevance to DNA-cleavage reaction. J Am Chem Soc 102:5419-5421
10. Frankel EN, Neff WE (1983) Formation of malonaldehyde from lipid oxidation products. Biochim Biophys Acta 754:264-270
11. Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189(1-2):147-163
12. Ghosh P, Kotchevar AT, DuMez DD, Ghosh S, Peiterson J, Uckun FM (1999) Synthesis and structure of bis(pi-cyclopentadienyl) vanadium(IV) 1,10-phenanthroline and 2,2′-bipyridine compounds and their interactions with artificial membranes. Inorg Chem 38(6):3730-3737
13. Gómez C, De la Garza JG, Arenas F, Ruiz-Ramírez L, Gracia-Mora MI (1993) Quimiosensibilidad in vitro de células de cáncer cérvico-uterino por efecto de Casiopeinas I, II y III. Tumor: Oncología Interdisciplinaria 6(4):136
14. Gracia-Mora MI, Ruiz-Ramírez L, Gómez-Ruiz C, Tinoco-Méndez M, Márquez-Quiñones A, Romero de Lira M, Marín-Hernández A, Macías-Rosales L, Bravo-Gómez ME (2001) Knights move in the periodic table, from copper to platinum, novel antitumor mixed chelate copper compounds, casiopeinas, evaluated by an in vitro human and murine cancer cell line panel. Metal Based Drugs 8:19-28
15. Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539-1543
16. Leuthauser WCS, Oberley WL, Oberley DT, Sorenson JRJ, Ramakrishna K (1981) Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. J Natl Cancer Inst 66:1077-1081
17. Liochev SI, Fridovich I (1992) Superoxide radical in Escherichia coli. In: Scandalios SG (ed) Molecular biology of free radical scavenging systems. Cold Spring Harbor Laboratory Press, pp 213-229
18. Marín HA, Gracia-Mora MI, Ruiz-Ramírez L, Moreno SR (2003) Toxic effects of copper based antineoplastic drugs (Casiopeinas®) on mitochondrial functions. Biochem Pharmacol 65:1979-1989
19. Mark HF, Othmer DF, Overberger CG, Seaborg GT (1979) Encyclopedia of chemical technology, 3rd edn, vol 5-6. Interscience Publishers (Wiley), New York
20. Martell AF, Calvin M (1952) Chemistry of the metal chelate compounds. Prentice-Hall, New York, pp 112-119
21. Ruiz-Azuara L. Mexican Patent SECOFI Enero 26, 172967 (1994). Mexican Patent SECOFI Dic. 9 (1993) 172248. USA Patent April. 21 (1992) Number 5, 107, 005. Re. Feb 18 (1997) 35,458. USA Patent Nov. 19 (1996) 5,576,326. Patent application UE and Japan Anticarcinogenic agents. Type A and B
22. Penta JS, Johnson FM, Wachsman JT, Copeland WC (2001) Mitochondrial DNA in human malignancy. Mutat Res 488(2):119-133
23. Pindur U, Haber M, Sattler K (1993) Antitumor active drugs as intercalators of deoxyribonucleic acid. Molecular models of intercalation complexes. J Chem Educ 70(4):263-272
24. Ruiz-Ramírez L, De la Rosa ME, Gracia-Mora MI, Mendoza A, Pérez G, Breña VM, Gutiérrez P, Pimentel E, Cruces MMP, Natarajan AT (1995) Casiopeina, metal based drugs: a new class of antineoplastic and genotoxic compounds. J Inorg Biochem 59(2-3):207
25. Ruiz-Ruiz L, Gracia-Mora MI, De la Rosa ME, Sumano H, Gómez C, Arenas F, Pimentel E, Cruces MMP (1993) Antineoplastic activities and preliminary toxicity of copper (II) new drugs: Casiopeinas I, II, III. J Inorg Biochem 51(1-2):406
26. Ruiz-Ramírez L, Gracia-Mora MI, Moreno ER, Gasque L, Huerta L, Mayet L, Ortiz V, Lomelí C (1991) The antitumor activity of several transition metal complexes. J Inorg Biochem 43(2-3):615
27. Rundell MS, Wagner ED, Plewa JM (2003) The comet assay: genotoxic damage or nuclear fragmentation? Environ Mol Mutagen 42:61-67
28. Samuni A, Aronovitch J, Godinger D, Chevion M, Czapski G (1983) On the cytotoxicity of vitamin C and metal ions. A site specific Fenton mechanism. Eur J Biochem 137(1-2):119-124
29. Sharpe AG (1992) Inorganic chemistry, 3rd edn. Longman Scientific and Technical, USA
30. Sigman SD, Mazumder A, Perrin MD (1993) Chemical nucleases. Chem Rev 93:2295-2316
31. Strauss GHS (1991) Non-random cell killing in cryopreservation: implications for performance of the battery of leukocyte test (BLT). I. Toxic and immunotoxic effects. Mutat Res 252:1-15
32. Tatsuta M, Iishi H, Baba M, Mikuni T, Narahara H, Uedo N, Yano H (2003) Suppression by iron chelator phenanthroline of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N′-nitro-N- nitrosoguanidine in Wistar rats. Cancer Lett 191(1):9-16
33. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kabayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (35):206-221
34. Trejo SC, Palencia G, Zúñiga S, Rodríguez RA, Osorio RL, Sánchez TL, Gracia-Mora MI, Márquez RL, Sánchez A, Moreno GME, Cruz A, Bravo GME, Ruiz-Ramírez L, Rodríguez ES, Sotelo J (2005) Cas IIGly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms. Neoplasia 7(6):563-574
35. Yajima N, Hiraishi H, Harada T (1995) Protection of cultured rat gastric cells against oxidant stress by iron chelation. Role of lipid peroxidation. Dig Dis Sci 40(4):879-886